Pharmacoepidemiology and pharmacovigilance in pregnancy: experience of the regional service of clinical pharmacology

• Autori principali: E V Eliseeva (Autore), Yu V Feoktistova (Autore), E A Poddubnyi (Autore), I I Shmykova (Autore), R K Goncharova (Autore)
• Natura: Libro
• Pubblicazione: IP Berlin A.V., 2013-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Riassunto

One of the priority healthcare tasks is the prevention of congenital malformations at all stages - pregravidal, prenatal and postnatal. The analysis of 1306 pregnant women' pharmacotherapy was carried out. 27,93% of the prescribed drugs were relatively safe for the fetus (category A, B). The most commonly used (36,12%) drugs were the ones with undetermined safety level (N FDA- Food and Drug Administration). In 35,93% of cases drugs with the risk of teratogenicity or embryotoxicity effects to the fetus (category C, D, X) were used.

Descrizione del documento

2079-5696
2079-5831